Bank of the West’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,336
Closed -$404K 218
2021
Q4
$404K Hold
2,336
0.04% 191
2021
Q3
$339K Buy
+2,336
New +$342K 0.04% 190

Other funds holding DGX

Bank of the West's DGX Position: Q1 2022 in Review

Bank of the West sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 2,336 shares — an estimated $404K sold.

Bank of the West first reported a position in DGX in Q3 2021 and held it in 2 quarters. The position peaked at $404K in Q4 2021. 852 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • Bank of the West reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
  • Bank of the West sold 2,336 Quest Diagnostics shares in Q1 2022, an estimated $404K.
  • Bank of the West first reported a position in Quest Diagnostics in Q3 2021 and held it in 2 quarters.
  • Bank of the West's Quest Diagnostics position peaked at $404K in Q4 2021.
  • 852 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Bank of the West's 13F filing for Q1 2022, filed 22 Apr 2022.